Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
18–70
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Group A:
Male and female subjects between the ages of 18 and 70 years
Group B:
Male and female subjects between the ages of 18 and 70 years
History of asthma
No use of oral or inhaled corticosteroids for the treatment of asthma in the past 6 weeks
Hyperreactivity to methacholine (PC20FEV1 Methacholine ≤ 8.0 mg/mL)
At least one of the following symptoms, beta agonist use, or FEV1 criteria:
* Asthma symptoms on at least two days per week; OR
* Beta agonist use on at least two days per week; OR
* FEV1 \< 85% predicted
Groups A \& B:
You may not be if
Current smokers (smoking within the last 12 months) or former smokers who have a total pack-year smoking history greater than 10
Pregnant women
Subjects with a history of lung disease other than asthma
Subjects with a history of a medical disease, which in the opinion of the investigator may put the subject at extra risk from study-related procedures or because the disease may influence the results of the study
Clareo Health | Role of microRNAs in T Cell-Driven Inflammation in Asthma
